EUVIMEDEUVIMED entdecken
Editorial

Perfluoroalkyl Substances and Estrogen Receptor‑Negative Breast Cancer: Looking Beyond Traditional Risk Factors

Veronica Wendy Setiawan iD

Journal of Clinical Oncology · 05.11.2026

DOI: 10.1200/jco-26-02225 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Clinical Oncology, online erschienen am 05.11.2026. Verfasst von Veronica Wendy Setiawan. Beteiligte Einrichtung: Department of Population and Public Health Sciences, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, …. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Population and Public Health Sciences, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.

ORCID-Profile: Veronica Wendy Setiawan

Zitieren

APA

Setiawan, V. W. (2026). Perfluoroalkyl Substances and Estrogen Receptor‑Negative Breast Cancer: Looking Beyond Traditional Risk Factors. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-02225

Vancouver

Setiawan VW. Perfluoroalkyl Substances and Estrogen Receptor‑Negative Breast Cancer: Looking Beyond Traditional Risk Factors. Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-02225

BibTeX
@article{Setiawan2026,
  author = {Setiawan, Veronica Wendy},
  title = {Perfluoroalkyl Substances and Estrogen Receptor‑Negative Breast Cancer: Looking Beyond Traditional Risk Factors},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1200/jco-26-02225}
}
Kostenlos starten →